Skip to main content
Log in

Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency

  • Clinical nephrology / Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract 

A patient with homozygous factor H deficiency presented with hemolytic uremic syndrome (HUS) at the age of 7 months. After a 2-year period of stability, renal failure and erythrocyte fragmentation recurred between the age of 3 and 4 years. Fresh frozen plasma infusions allowed renal function to be improved and erythrocyte fragmentation to be stopped. Withdrawal of plasma therapy led to a relapse of the biological signs of HUS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 18 April 2000 / Revised: 18 August 2000 / Accepted: 21 August 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nathanson, S., Frémeaux-Bacchi, V. & Deschênes, G. Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency. Pediatr Nephrol 16, 554–556 (2001). https://doi.org/10.1007/s004670100609

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004670100609

Navigation